Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fardokht A Abulwerdi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods (San Diego, Calif.)|April 26, 2016
Microarray-based technologies for the discovery of selective, RNA-binding moleculesFardokht A Abulwerdi, John S Schneekloth
Current Pharmaceutical Design|June 20, 2017
Recent Advances in Targeting the HIV-1 Tat/TAR ComplexFardokht A Abulwerdi, Stuart F J Le Grice
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
Discovery of RNA Binding Small Molecules Using Small Molecule MicroarraysColleen M Connelly, Fardokht A Abulwerdi, John S Schneekloth
Journal of Virology|March 6, 2015
BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected CellsOlesea Cojohari, Christine M Burrer, Megan A Peppenelli, et al.
Antiviral Research|December 5, 2016
Mcl-1 small-molecule inhibitors encapsulated into nanoparticles exhibit increased killing efficacy towards HCMV-infected monocytesChristine M Burrer, Helen Auburn, Xu Wang, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNAFardokht A Abulwerdi, Matthew D Shortridge, Joanna Sztuba-Solinska, et al.
Journal of Medicinal Chemistry|April 23, 2014
3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluationFardokht A Abulwerdi, Chenzhong Liao, Ahmed S Mady, et al.
Translational Oncology|March 10, 2015
Targeting mcl-1 for radiosensitization of pancreatic cancersDongping Wei, Qiang Zhang, Jason S Schreiber, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
HIV-1 Transcription Inhibition Using Small RNA-Binding MoleculesPooja Khatkar, Gifty Mensah, Shangbo Ning, et al.
ACS Chemical Biology|January 9, 2019
Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1Fardokht A Abulwerdi, Wenbo Xu, Abeer A Ageeli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods (San Diego, Calif.)|April 26, 2016
Microarray-based technologies for the discovery of selective, RNA-binding moleculesFardokht A Abulwerdi, John S Schneekloth
Current Pharmaceutical Design|June 20, 2017
Recent Advances in Targeting the HIV-1 Tat/TAR ComplexFardokht A Abulwerdi, Stuart F J Le Grice
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
Discovery of RNA Binding Small Molecules Using Small Molecule MicroarraysColleen M Connelly, Fardokht A Abulwerdi, John S Schneekloth
Journal of Virology|March 6, 2015
BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected CellsOlesea Cojohari, Christine M Burrer, Megan A Peppenelli, et al.
Antiviral Research|December 5, 2016
Mcl-1 small-molecule inhibitors encapsulated into nanoparticles exhibit increased killing efficacy towards HCMV-infected monocytesChristine M Burrer, Helen Auburn, Xu Wang, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNAFardokht A Abulwerdi, Matthew D Shortridge, Joanna Sztuba-Solinska, et al.
Journal of Medicinal Chemistry|April 23, 2014
3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluationFardokht A Abulwerdi, Chenzhong Liao, Ahmed S Mady, et al.
Translational Oncology|March 10, 2015
Targeting mcl-1 for radiosensitization of pancreatic cancersDongping Wei, Qiang Zhang, Jason S Schreiber, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
HIV-1 Transcription Inhibition Using Small RNA-Binding MoleculesPooja Khatkar, Gifty Mensah, Shangbo Ning, et al.
ACS Chemical Biology|January 9, 2019
Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1Fardokht A Abulwerdi, Wenbo Xu, Abeer A Ageeli, et al.
Pageof 2